BR9609014A - Medicamentos para tratar um mamìfero sofrendo de uma desordem epitelial e para tratar um mamìfero sofrendo de inflamação mediana por células t ou dependentes de células t da pele de um mamìfero - Google Patents

Medicamentos para tratar um mamìfero sofrendo de uma desordem epitelial e para tratar um mamìfero sofrendo de inflamação mediana por células t ou dependentes de células t da pele de um mamìfero

Info

Publication number
BR9609014A
BR9609014A BR9609014-6A BR9609014A BR9609014A BR 9609014 A BR9609014 A BR 9609014A BR 9609014 A BR9609014 A BR 9609014A BR 9609014 A BR9609014 A BR 9609014A
Authority
BR
Brazil
Prior art keywords
cell
treat
mammal
mammal suffering
medicines
Prior art date
Application number
BR9609014-6A
Other languages
English (en)
Inventor
Howard L Weiner
Thomas S Kupper
Youhai Chien
Original Assignee
Autoimmune Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Autoimmune Inc filed Critical Autoimmune Inc
Publication of BR9609014A publication Critical patent/BR9609014A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

"MEDICAMENTOS PARA TRATAR UM MAMìFERO SOFRENDO DE UMA DESORDEM EPITELIAL E PARA TRATAR UM MAMìFERO SOFRENDO DE INFLAMAçãO MEDIADA POR CéLULAS T OU DEPENDENTE DE CéLULAS T DA PELE DE UM MAMìFERO", para tratamento de doenças epiteliais apresentando inflamação mediada por células T ou dependentes de células T. A invenção relaciona-se a métodos e composições para o tratamento de tais doenças através da administração oral de um antígeno espectador associado à pele.
BR9609014-6A 1995-06-07 1996-06-05 Medicamentos para tratar um mamìfero sofrendo de uma desordem epitelial e para tratar um mamìfero sofrendo de inflamação mediana por células t ou dependentes de células t da pele de um mamìfero BR9609014A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48619095A 1995-06-07 1995-06-07
PCT/US1996/010384 WO1996040232A1 (en) 1995-06-07 1996-06-05 Oral tolerance in skin diseases presenting with t-cell mediated inflammation

Publications (1)

Publication Number Publication Date
BR9609014A true BR9609014A (pt) 1999-12-14

Family

ID=23930947

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9609014-6A BR9609014A (pt) 1995-06-07 1996-06-05 Medicamentos para tratar um mamìfero sofrendo de uma desordem epitelial e para tratar um mamìfero sofrendo de inflamação mediana por células t ou dependentes de células t da pele de um mamìfero

Country Status (10)

Country Link
EP (1) EP0871478A1 (pt)
JP (1) JPH11507383A (pt)
KR (1) KR19990022556A (pt)
AU (1) AU6333796A (pt)
BR (1) BR9609014A (pt)
CA (1) CA2219457A1 (pt)
HU (1) HUP9901077A3 (pt)
IL (1) IL122502A0 (pt)
NO (1) NO975554D0 (pt)
WO (1) WO1996040232A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999064066A1 (fr) * 1998-06-09 1999-12-16 Shionogi & Co., Ltd. Agents induisant une tolerance immunitaire et contenant de la keratine dure ou une substance ressemblant a la keratine
IL126447A (en) * 1998-10-04 2004-09-27 Vascular Biogenics Ltd An immune preparation that confers tolerance in oral administration and its use in the prevention and / or treatment of atherosclerosis
KR102027451B1 (ko) 2012-11-02 2019-10-02 (주)아모레퍼시픽 마이크로 rna 및 이를 사용하는 스크리닝 방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399347A (en) * 1987-06-24 1995-03-21 Autoimmune, Inc. Method of treating rheumatoid arthritis with type II collagen

Also Published As

Publication number Publication date
HUP9901077A2 (hu) 1999-07-28
WO1996040232A1 (en) 1996-12-19
EP0871478A1 (en) 1998-10-21
NO975554L (no) 1997-12-02
KR19990022556A (ko) 1999-03-25
HUP9901077A3 (en) 1999-11-29
IL122502A0 (en) 1998-06-15
JPH11507383A (ja) 1999-06-29
CA2219457A1 (en) 1996-12-19
NO975554D0 (no) 1997-12-02
AU6333796A (en) 1996-12-30

Similar Documents

Publication Publication Date Title
DK0871748T3 (da) Indgivelse af biologisk aktive polypeptider
DE69331409D1 (de) Oral 1alpha-hydroxyprevitamin d
BR9405798A (pt) Métodos para liberação in vivo de material biológico e composições úteis dos mesmos
BR9306042A (pt) Método para tratar uma doença auto-immune em um mamifero e formas de dosagens farmacêuticas oral e inalável
AU7573396A (en) Intraoral administration device and system
ES2172654T3 (es) Uso de nsaid para el tratamiento de carcinomas de celulas escamosas de la cavidad oral u orofaringe.
DK0914144T3 (da) Terapeutiske anvendelser af BPI-protein-produkter til human meningokokæmi
IT9048260A0 (it) Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione.
TR200002855T2 (tr) Raloksifenin solunum yolu ile veya burundan uygulanması.
NO20100061L (no) Forhindring og behandling av amyloidogen sykdom
MX9801596A (es) Composiciones aliviadoras del prurito, cosmeticas y farmaceuticas o ambas.
IT9048261A0 (it) Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione.
DE58902712D1 (de) N-acetylglucosamin-zubereitungen zur buccalen anwendung.
IT1255723B (it) Uso di paratormone,suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto pretermine ed in generale per il trattamento della gestazione
CA2120062A1 (en) Use of Sulodexide and of Medicines Containing It in the Treatment of Diabetic Nephropathy
PT835103E (pt) Nanoparticulas para administracao oral de agentes farmaceuticos de baixa solubilidade
BR9809678A (pt) Derivados de triptolìdeo úteis no tratamento de doenças autoimunes
BR9609014A (pt) Medicamentos para tratar um mamìfero sofrendo de uma desordem epitelial e para tratar um mamìfero sofrendo de inflamação mediana por células t ou dependentes de células t da pele de um mamìfero
GB9501826D0 (en) Polypeptide fragments
BR9809673A (pt) Derivados de triptolida úteis no tratamento de doenças autoimunes
GEP19991604B (en) Human Follicle Stimulating Hormone Receptor
DK1039931T3 (da) Multivalente rekombinante antistoffer til at behandle HRV infektioner
IL105498A0 (en) Pharmaceutical composition containing ribonucleotide polymerase
AU7439996A (en) Novel uses of mammalian ctla-8 and related reagents
PT1231908E (pt) Composicao farmaceutica compreendendo um composto dador de no e sua utilizacao em terapia

Legal Events

Date Code Title Description
FD5 Application fees: dismissal - article 86 of industrial property law